跳至主要内容
临床试验/JPRN-UMIN000030278
JPRN-UMIN000030278招募中未知

Prognostic impact of inflammatory-related biomarkers on the overall survival of patients with non-operable malignant pleural mesothelioma - Prognostic impact of inflammatory-related biomarkers on the overall survival of patients with non-operable malignant pleural mesothelioma

Hyogo Prefectural Amagasaki General Medical Center0 个研究点目标入组 140 人开始时间: 2017年12月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
15years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • MPM patients who received surgical treatment were excluded from this study. Patients who had active inflammatory disease (such as rheumatoid arthritis) or infection at the time of MPM diagnosis were excluded. Patients who were treated by chemotherapy or radiotherapy before the histological diagnosis of MPM, patients with MPM confirmed by autopsy, patients who had entered clinical trial study, patients with insufficient follow-up period (patients with follow-up period of less than one month after the diagnosis of MPM or patients who had received treatment at other hospitals after the diagnosis of MPM), were also excluded.

研究者

相似试验